Mylan N.V. (NASDAQ, TASE: MYL) today announced that its abbreviated new drug application (ANDA) for fluticasone propionate 100, 250, 500 mcg and salmeterol 50 mcg inhalation powder has been accepted ...

1. Wixela Inhub is Mylan’s generic version of Advair, an asthma treatment made by GlaxoSmithKline. 2. Tosymra is a sumatriptan nasal spray used to treat migraines in adults. 3. Imbruvica in ...

Mylan launched its generic version of GlaxoSmithKline’s asthma treatment Advair at a price 70 percent lower than the branded treatment, according to Reuters. The treatment, approved in January, is the ...

GlaxoSmithKline gains 2.7 percent after Novartis hands back U.S. rights to a drug widely thought to be a generic copy of its blockbuster Advair, reducing the threat of cheap copies of the lung drug in ...

LONDON (Reuters) - GlaxoSmithKline received a boost on Monday from a decision by Express Scripts , the largest U.S. pharmacy benefit manager, to reinstate its top-selling lung drug Advair as an ...

WASHINGTON—The blockbuster asthma drug Advair does not appear to have an increased risk of serious respiratory complications seen with similar new medicines, federal health officials said Friday. But ...